Health Canada drug identification number

DIN 02245664 — APO-TRIMEBUTINE 200 MG

APO-TRIMEBUTINE is a tablet of Trimebutine marketed by APOTEX INC. The full Trimebutine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02245664
Brand name
APO-TRIMEBUTINE
Active ingredient
Trimebutine
Strength
200 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
APOTEX INC
Health Canada status
MARKETED
Drug class
Gastrointestinal motility regulator (spasmolytic / antispasmodic)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Trimebutine products

DINBrandStrengthFormManufacturerStatus
02245663 APO-TRIMEBUTINE 100 MG TABLET APOTEX INC MARKETED
02538202 MINT-TRIMEBUTINE 100 MG TABLET MINT PHARMACEUTICALS INC MARKETED
02538210 MINT-TRIMEBUTINE 200 MG TABLET MINT PHARMACEUTICALS INC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.